An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 848, Issue 2, 2007, Pages 369-373

  Weller, Dennis R ^a   Brundage, Richard C ^b   Balfour Jr , Henry H ^a   Vezina, Heather E ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

HIV; HPLC UV; Isocratic; Liquid liquid extraction; Non nucleoside reverse transcriptase inhibitors; Protease inhibitors; Therapeutic drug monitoring

Indexed keywords

CONCENTRATION (PROCESS); DRUG THERAPY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMA SOURCES;

ISOCRATIC; LIQUID LIQUID EXTRACTION; NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS; PROTEASE INHIBITORS; THERAPEUTIC DRUG MONITORING;

ENZYME INHIBITION;

ABACAVIR; AMPRENAVIR; ATAZANAVIR; ATORVASTATIN; ATOVAQUONE; DAPSONE; DIDANOSINE; DRUG METABOLITE; EFAVIRENZ; FENOFIBRIC ACID; FLUCONAZOLE; INDINAVIR; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; SULFAMETHOXAZOLE; TENOFOVIR; ZIDOVUDINE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE LIQUID CHROMATOGRAPHY;

BENZOXAZINES; CARBAMATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; NELFINAVIR; NEVIRAPINE; OLIGOPEPTIDES; PYRIDINES; PYRIMIDINONES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; SAQUINAVIR; SPECTROPHOTOMETRY, ULTRAVIOLET; SULFONAMIDES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33947366781     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.10.022     Document Type: Article

References (12)

1. Marzolini C., Telenti A., Decosterd L.A., Greub G., Biollaz J., and Buclin T. AIDS 15 (2001) 1192
2. Gonzalez de Requena D., Bonora S., Marrone R., D'Avolio A., Sciandra M., Milia M., Di Garbo A., Sinicco A., and Di Perri G. Program and Abstracts of the 12th Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, Alexandria, VA (2005) 296
3. Dieleman J.P., Gyssens I.C., van der Ende M.E., de Marie S., and Burger D.M. AIDS 13 (1999) 473
4. Fletcher C.V., Jiang H., Brundage R.C., Acosta E.P., Haubrich R., Katzenstein D., and Gulick R.M. J. Infect. Dis. 189 (2004) 1176
5. Droste J.A.H., Verweij-van Wissen C.P.W.G.M., and Burger D.M. Ther. Drug Monit. 25 (2003) 393
6. Keil K., Frerichs V.A., DiFrancesco R., and Morse G.D. Ther. Drug Monit. 25 (2003) 340
7. Rezk N., Tidwell R.R., and Kashuba A.D.M. J. Chromatogr. B 805 (2004) 241
8. Dailly E., Rafi F., and Jolliet P. J. Chromatogr. B 813 (2004) 353
9. Poirier J., Robidou P., and Jaillon P. Ther. Drug Monit. 27 (2005) 186
10. Takahashi M., Yoshida M., Oki T., Okumura N., Suzuki T., and Kaneda T. Biol. Pharm. Bull. 28 (2005) 1286
11. Holland D.T., DiFrancesco R., Stone J., Hamzeh F., Connor J.D., and Morse G.D. Adult and pediatric AIDS clinical trials group pharmacology laboratory committees, Pediatric AIDS clinical trials group. Antimicrob. Agents Chemother. 48 (2004) 824
12. PubChem Compound, Tipranavir, available at http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=65027, accessed September 14, 2006.